Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

90.97 -0.76 (-0.83%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Elon Musk’s Neuralink Faces New FDA-Approved Rival In Precision Neuroscience
The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue. 
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Nvidia Drags Wall Street Down, Gold Defies Gravity Ahead Of Powell Remarks: What's Driving Markets Wednesday?
U.S. major indices traded lower at midday Wednesday, pressured by sharp declines in tech and semiconductor stocks after Washington tightened chip export restrictions to China. 
Via Benzinga
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
From FN Media Group LLC
Via GlobeNewswire
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Analyst Expectations For Medtronic's Future
 
Via Benzinga
Medtronic Stock Gets IBD Rating Lift
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier. 
Via Investor's Business Daily
Is MEDTRONIC PLC (NYSE:MDT) a Good Fit for Dividend Investing?
Analyzing MEDTRONIC PLC (NYSE:MDT)'s Dividend Potential. 
Via Chartmill
3 Top Dividend Stocks to Buy and Hold for the Next 20 Years
Via The Motley Fool
Topics Economy
Looking Into Medtronic's Recent Short Interest
 
Via Benzinga
2 Value Stocks I'm Buying Right Now
Via The Motley Fool
Topics Economy
Step Into Spring – Don't Let Varicose Veins Stop You
(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of... 
Via NewsUSA
Why Medtronic Stock Marched Higher on Monday
Via The Motley Fool
Pain Neuromodulation Market to Reach $6.5 Billion by 2030
SAN FRANCISCO, Calif., March 31, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the newsletter Neurotech Business Report, announced the availability of a new market research report... 
Via Send2Press
Prediction: Buying Medtronic Today Will Set You Up for Life
Via The Motley Fool
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
2 Recession-Proof Dividend Stocks to Buy and Hold
Via The Motley Fool
Spring Into Action – Don't Let Varicose Veins Hold You Back
(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of... 
Via NewsUSA
China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid... 
Via Benzinga
Topics World Trade
Spring Forward – Don’t Let Varicose Veins Hold You Back
(NewsUSA) - As the cold of winter fades, spring brings a fresh sense of renewal—and for many, it’s the first time in months they’ll be showing off their legs again. But for some, the thought of... 
Via NewsUSA
Why MEDTRONIC PLC (NYSE:MDT) provides a good dividend, while having solid fundamentals.
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT). 
Via Chartmill
5 Dividend Stocks That Motley Fool Experts Are Watching Right Now
Via The Motley Fool
Biogen VP to Keynote 2025 Bioelectronic Medicine Forum in NYC
NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual... 
Via Send2Press
Kroger CEO Shake-Up
Via The Motley Fool
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
From FN Media Group LLC
Via GlobeNewswire
Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:ACON),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
2 Dependable Dividend Stocks That Can Pay You for Life
Via The Motley Fool
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
MEDTRONIC PLC (NYSE:MDT) is setting up nicely for a breakout.
MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.